Persistence and geographic availability of Medicare Part D coverage for non-diabetes GLP-1 therapies, 2024-2026

Eunhae Shin, Alice Chen

Open source

DOI
10.1093/haschl/qxag299
Published
2026-10-25
Container
Health Affairs Scholar
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/haschl/qxag299,
  title = {Persistence and geographic availability of Medicare Part D coverage for non-diabetes GLP-1 therapies, 2024-2026},
  author = {Eunhae Shin and Alice Chen},
  year = {2026},
  journal = {Health Affairs Scholar},
  doi = {10.1093/haschl/qxag299},
  url = {https://doi.org/10.1093/haschl/qxag299}
}

RIS

TY  - JOUR
TI  - Persistence and geographic availability of Medicare Part D coverage for non-diabetes GLP-1 therapies, 2024-2026
AU  - Eunhae Shin
AU  - Alice Chen
PY  - 2026
JO  - Health Affairs Scholar
DO  - 10.1093/haschl/qxag299
UR  - https://doi.org/10.1093/haschl/qxag299
ER  - 

APA

Shin, E., & Chen, A. (2026). Persistence and geographic availability of Medicare Part D coverage for non-diabetes GLP-1 therapies, 2024-2026. Health Affairs Scholar. https://doi.org/10.1093/haschl/qxag299

Source records